| Name | Title | Contact Details |
|---|
EverlyWell believes that health tests shouldn`t be hard to get – or hard to understand. The EverlyWell experience is simple. You order one of our kits online, you collect your sample from home and return it via pre-paid mail to one of our fully-certified partner laboratories. A board-certified physician in your state will review and validate your results before you get them. EverlyWell provides a complete, easy-to-read results report online in just a few days. Our comprehensive test kits measure key biomarkers through dried blood spot, urine or saliva samples that are collected in the comfort of your home. EverlyWell empowers individuals by providing easy access to health data. We are proud to offer a suite of direct-to-consumer, regulatory-compliant tests…without a lab visit.
Found is a modern weight care platform pioneering integrated support through personalized coaching, online community, and if indicated, prescription medication. We believe that weight care is complex and goes beyond having the willpower to eat less and move more. We believe in the power of biology, genetics, sleep, stress, mental health and daily habits and we work with each factor to achieve long-lasting results. Our goals are to address the long-term risks associated with ineffective weight management, to reimagine the narrow and outdated cultural narrative around weight, and to empower our community with tools that will help them find self-acceptance and add years to their lives. We believe it`s not just what you`ve lost, it`s what you`ve Found.
Windsor House Inc is a Girard, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol "SYN". The Company`s principal executive offices are located in Rockville, MD, and the finance and administrative office is located in Ann Arbor, MI. Synthetic Biologics, Inc. is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company`s lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat the underlying cause of irritable bowel syndrome with constipation (IBS-C). In addition, the Company is developing a monoclonal antibody combination for the treatment of Pertussis, and a Phase 2 oral estriol drug for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS.
Since opening its doors in 1957, Southeast Health has provided for the changing healthcare needs of the growing communities it serves which includes about 600,000 residents neighboring communities and counties of Southeast Alabama, Southwest Georgia and the Florida Panhandle. Our progress represents the culmination of distinguished service by dedicated board members, physicians, employees and volunteers, and a supportive community. It takes more than technology and a modern facility to treat people. It takes a team of dedicated, well-trained professionals to continually deliver quality healthcare. Employing about 2,500, Southeast Health is recognized as one of the largest employers in the region and is proud of its reputation of providing a positive and responsive work environment. Southeast Health`s medical staff consists of more than 225 active members and just over 400 total members either board certified or board prepared in specialties representing virtually every area of medicine. Through innovation and sustained performance, Southeast Health, a 420-bed regional referral center, has achieved the reputation of providing the best diagnostic, clinical, surgical and patient care services available in the region.